EUVIMEDEUVIMED entdecken
Crossref

Oral Milk-Derived Extracellular Vesicles: A Promising Drug Delivery System for Neuroinflammatory Diseases

Ming-Yue Bao, Yan-Hua Li, Zhe-An Zhou iD, Lin-Jie Zhang, Xin-Yan Han, Xin-Ya Guo, Xiao-Yan Guo, Meng-Yuan Tian, Dong-Xia Hao, Wei-Feng Zhang, Xiao-Li Ding, Yuan Zhang iD und 1 weitere

ACS Biomaterials Science & Engineering · 2026

DOI: 10.1021/acsbiomaterials.6c00969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2026. Verfasst von Ming-Yue Bao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education; College of Life Sc…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Drug Delivery Systems, Extracellular Vesicles, Ellagic Acid. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Shanxi Provincial Science and Technology Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral drug delivery is the most patient-friendly and safest approach for disease treatment; however, the bioavailability of macromolecular drugs and poorly soluble small molecules is severely limited by gastrointestinal degradation and the blood−brain barrier (BBB). Here, we developed a cost-effective, chitosan-based isolation method to efficiently isolate milk-derived extracellular vesicles (mEVs), which exhibit good stability in the gastrointestinal tract and intrinsic BBB-penetrating capability. Biodistribution studies showed that mEVs were absorbed in both healthy and experimental autoimmune encephalomyelitis (EAE) mice, with increased CNS accumulation under neuroinflammation, especially in oligodendrocytes and neurons. To address the poor stability and bioavailability of ellagic acid (EA) and to explore the therapeutic potential of mEVs in neuroinflammation treatment, we encapsulated EA and interferon-β (IFN-β) into mEVs and evaluated their therapeutic effects in experimental autoimmune encephalomyelitis (EAE) and lipopolysaccharide-induced neuroinflammation models. The results showed that mEV@IFN-β and mEV@EA significantly relieved disease progression and improved neuroinflammation compared to free drugs, with enhanced stability and bioavailability. Overall, our study findings establish mEVs as an efficient oral delivery platform capable of overcoming biological barriers for treating neuroinflammatory diseases, with the chitosan-based isolation method offering a scalable production approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalDrug Delivery SystemsExtracellular VesiclesEllagic AcidMilkNeuroinflammatory DiseasesDrug CarriersAnimalsAdministration, OralMiceFemaleInterferon-betaMice, Inbred C57BLChitosanBlood-Brain BarrierTissue Distribution

Stichwörter der Autor:innen

ellagic acidinterferon-βmEVsneuroinflammatory diseasesoral drug delivery system

Substanzen

Ellagic AcidInterferon-betaChitosanDrug Carriers

Autor:innen und Institutionen

  • Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education; College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi710119, China.
  • Datong Key Laboratory of Smart Medicine and Health Care for Elderly Chronic Diseases, Shanxi Datong University School of Medicine, Datong, Shanxi037009, China.
  • Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi710119, China.

ORCID-Profile: Zhe-An Zhou, Yuan Zhang, Xing Li

Förderung

  • Fundamental Research Funds for the Central Universities
  • Shanxi Provincial Science and Technology Department

Zitieren

APA

Bao, M. Y., Li, Y. H., Zhou, Z. A., Zhang, L. J., Han, X. Y., Guo, X. Y., Guo, X. Y., Tian, M. Y., Hao, D. X., Zhang, W. F., Ding, X. L., Zhang, Y., & Li, X. (2026). Oral Milk-Derived Extracellular Vesicles: A Promising Drug Delivery System for Neuroinflammatory Diseases. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.6c00969

Vancouver

Bao MY, Li YH, Zhou ZA, Zhang LJ, Han XY, Guo XY, et al. Oral Milk-Derived Extracellular Vesicles: A Promising Drug Delivery System for Neuroinflammatory Diseases. ACS Biomaterials Science & Engineering. 2026. doi:10.1021/acsbiomaterials.6c00969

BibTeX
@article{Bao2026,
  author = {Bao, Ming-Yue and Li, Yan-Hua and Zhou, Zhe-An and Zhang, Lin-Jie and Han, Xin-Yan and Guo, Xin-Ya and Guo, Xiao-Yan and Tian, Meng-Yuan and Hao, Dong-Xia and Zhang, Wei-Feng and Ding, Xiao-Li and Zhang, Yuan and Li, Xing},
  title = {Oral Milk-Derived Extracellular Vesicles: A Promising Drug Delivery System for Neuroinflammatory Diseases},
  journal = {ACS Biomaterials Science & Engineering},
  year = {2026},
  doi = {10.1021/acsbiomaterials.6c00969}
}
Kostenlos starten →